Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens
Cancer Cytopathology · 2026-06 · 134 (6)
DOI: 10.1002/cncy.70114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 15.05.2026. Verfasst von Azusa Kai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, Biomarkers, Tumor, Lymphocytes, Tumor-Infiltrating. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Tumor‐infiltrating lymphocytes are prognostic and predictive biomarkers of breast cancer; however, conventional assessment is hindered by invasiveness and subjective evaluation, limiting clinical reproducibility. This study investigated the utility of microRNA (miRNA) profiles in predicting lymphocyte‐predominant breast cancer (LPBC).
Methods
This study included 56 patients with breast cancer who underwent fine‐needle aspiration cytology at the time of diagnosis (28 LPBC and 28 non‐LPBC cases). Total RNA was extracted from cytology smear specimens, and the expression levels of six candidate miRNAs (miR‐30a‐3p, miR‐187, miR‐196b, miR‐1247, miR‐4485, and miR‐6510) were quantified using reverse‐transcriptase polymerase chain reaction. The performance in identifying LPBC was evaluated using receiver operating characteristic curve analysis and logistic regression models.
Results
All six miRNAs showed significantly lower expression levels in the LPBC group than in the non‐LPBC group (all p < .05). Receiver operating characteristic curve analysis demonstrated moderate to high diagnostic accuracy, with an area under the curve of 0.708 for miR‐30a‐3p, 0.739 for miR‐187, 0.783 for miR‐196b, 0.777 for miR‐1247, 0.790 for miR‐4485, and 0.673 for miR‐6510. Multivariate analysis further identified each miRNA as an independent diagnostic predictor for LPBC. Conclusions miRNA profiling of cytologic samples enabled the objective identification of LPBC. These findings suggest that specific miRNA expression patterns reflect the tumor immune microenvironment and can be used to evaluate the status of tumor‐infiltrating lymphocytes in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
- Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
ORCID-Profile: Azusa Kai
Zitieren
APA
Kai, A., Arihiro, K., Shigematsu, H., Ohue-Uchihata, Y., Nakamura, M., Amioka, A., Sasada, S., & Okada, M. (2026). Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens. Cancer Cytopathology, 134(6). https://doi.org/10.1002/cncy.70114
Vancouver
Kai A, Arihiro K, Shigematsu H, Ohue-Uchihata Y, Nakamura M, Amioka A, et al. Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens. Cancer Cytopathology. 2026;134(6). doi:10.1002/cncy.70114
BibTeX
@article{Kai2026,
author = {Kai, Azusa and Arihiro, Koji and Shigematsu, Hideo and Ohue-Uchihata, Yukari and Nakamura, Momoko and Amioka, Ai and Sasada, Shinsuke and Okada, Morihito},
title = {Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens},
journal = {Cancer Cytopathology},
year = {2026},
volume = {134},
number = {6},
doi = {10.1002/cncy.70114}
}
EUVIMED